Authors: Andrievskaya S.A., Bessmertnaya A.A., Andrievsky A.G., Krotenko V.K.
1 Odessa National Medical University, Odessa, Ukraine
2 Odessa Regional Cardiology Center, Odessa, Ukraine
The article highlights the problem of the comorbidity of ischemic heart disease in combination with chronic venous insufficiency (CVI), which is widespread in the population (~ 50%), but remains insufficiently studied. In order to study new possibilities of optimal therapy for this combined pathology, the drug carbarutin (manufactured by WORLD MEDICINE, Turkey) was studied for patients suffering from coronary artery disease and CVI of various degrees in the day hospital with the cardiac profile and outpatient clinic. An integral assessment of the validity of using the combination in 30 patients with coronary artery disease and CVI is given based on the dynamics of clinical and functional criteria, as well as using general and specific questionnaires for patients with venous disease. The analysis of the quality of life proved the effectiveness of the drug carbarutin in the complex treatment of comorbid patients with IHD and CVI, the expediency of widespread use, taking into account the prevalence of CVI on the background of IHD in modern clinical practice.
Published in a journal «Recipe» Vol 23 № 5’2020